Tag Archives: Single Convention on Narcotic Drugs

Russia Says Canada Weed Legalization Is a ‘Breach’ of International Legal Obligations

GettyImages-670841700

By Jason Lemon On 6/25/18

Russia has come out strongly against Canada’s decision to legalize recreational marijuana, calling the move a “breach” of its “international legal obligations.”

The Russian Foreign Ministry said that a number of international conventions, to which Canada is a signatory, require privy nations to restrict the use of cannabis and other drugs to only medical and scientific purposes.

“We expect Canada’s partners in the G-7 to respond to its ‘high-handedness’ because this alliance has repeatedly declared its adherence to the domination of international law in relations between states,” the ministry said in an official statement.

Last week, Canada became the second nation in the world and the first member of the wealthy G-7 to pass legislation to legalize recreational marijuana. The U.S. neighbor plans to implement the new regulations on October 17. Uruguay was the first nation to legalize recreational marijuana, with legislation passed in 2013.

Canada has previously endorsed the 1961 Single Convention on Narcotic Drugs, the 1971 Convention of Psychotropic Substances and the 1988 U.N. Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. The U.S. is also a prominent signatory of the conventions. Despite the legalization of recreational marijuana in nine states and the nation’s capital, the U.S. claims to be abiding by the conventions as cannabis remains completely illegal at the federal level.

Although President Barack Obama’s administration instructed federal law enforcement not to interfere in lawful marijuana businesses in states where it has been legalized, President Donald Trump’s attorney general, Jeff Sessions, has urged federal agents to do the opposite. Opposition to legal marijuana at the federal level has also caused tensions with national banks and lawful cannabis businesses in the U.S.

Keep up with this story and more by subscribing now

Top U.S. banks have refused to do business with Uruguayan banks that manage money from legal cannabis sales. U.S. banks have cited federal regulations against drug trafficking and money laundering. Sessions also reportedly warned Canadian lawmakers prior to Ottawa’s vote, saying that legalization could cause problems for Canadian citizens when entering the U.S.

Although it remains unclear whether banks will take a similar stance when it comes to Canada, Hannah Hetzer, senior international policy manager at Drug Policy Alliance, believes the U.S. neighbor’s prominence could shelter it from a similar fallout.

“It really remains to be seen if U.S. banks will do the same for Canadian banks,” Hetzer told Newsweek. “We might just see that U.S. banks decide to say nothing in this case,” she said but added that “it could create an obstacle” if banks decide to take a stance against Ottawa’s new policy.

Hetzer also argued that citing federal anti-trafficking and money laundering laws to block business surrounding legal marijuana is counterintuitive. She explained that legalization and regulation work precisely to combat and undermine the criminal market.

The U.S. Justice Department declined to comment when asked by Newsweek about how it would respond to Canada’s decision. The U.S. Treasury Department did not immediately respond to a request for comment.

When it comes to Russia’s condemnation, Hetzer said she believes this will add up to little more than critical statements. “Canada is aware that there will be international opposition from some countries,” as well as that its move could “violate international drug control treaties,” Hetzer said. “But like Uruguay, Canada has said they are [legalizing marijuana] for the health and safety of their citizens,” she pointed out, explaining that the preamble to the international drug control treaty says that the health and welfare of mankind must be taken into consideration.

With just over 60 percent of Americans supporting legalized recreational marijuana, according to a January poll by Pew Research, and growing bipartisan support for decriminalization and legalization, some have suggested that the U.S. could potentially move to legalize at the federal level as well.

“Having a huge legal market in a mature, democratic neighbor is going to be a very significant signal to some of the holdouts that we have currently,” Democratic Representative Earl Blumenauer of Oregon, who leads the Congressional Cannabis Caucus, told Mother Jones prior to Ottawa’s decision. “It’s another step—not toward just legalization but also normalizing it.”

CONTINUE READING…

Advertisements

RE: International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Ocfentanil, Carfentanil, Pregabalin, Tramadol, Cannabidiol, Ketamine, and Eleven Other Substances; Request for Comments

The information contained herein is from the Government website of REGULATIONS.GOV.

They are currently seeking comments on the scheduling of the above named substances.  After browsing through the information I did not see CANNABIS included in this request.

 Cannabidiol, IS INCLUDED. 

I will submit my comments and will post my response here on the website.

Image result for psychotropic substances

Summary

The Food and Drug Administration (FDA) is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 17 drug substances. These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs. This notice requesting comments is required by the Controlled Substances Act (the CSA).

Dates

Submit either electronic or written comments by September 13, 2017.

Supplementary Information

I. Background

The United States is a party to the 1971 Convention on Psychotropic Substances (Psychotropic Convention). Article 2 of the Psychotropic Convention provides that if a party to the convention or WHO has information about a substance, which in its opinion may require international control or change in such control, it shall so notify the Secretary-General of the United Nations (the U.N. Secretary-General) and provide the U.N. Secretary-General with information in support of its opinion.

Section 201 of the CSA (21 U.S.C. 811) (Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970) provides that when WHO notifies the United States under Article 2 of the Psychotropic Convention that it has information that may justify adding a drug or other substances to one of the schedules of the Psychotropic Convention, transferring a drug or substance from one schedule to another, or deleting it from the schedules, the Secretary of State must transmit the notice to the Secretary of Health and Human Services (Secretary of HHS). The Secretary of HHS must then publish the notice in the Federal Register and provide opportunity for interested persons to submit comments that will be considered by HHS in its preparation of the scientific and medical evaluations of the drug or substance.

Links to further information and to post comments:

Docket ID: FDA-2017-N-4515

Agency: Food and Drug Administration (FDA)

Parent Agency: Department of Health and Human Services (HHS)

*View all documents and comments in this Docket

*Public Comments that have already been received and posted.

*SUBMIT YOUR COMMENT THROUGH THIS LINK

*LINK TO DOCUMENTATION IN THE FEDERAL REGISTER